HealthTree Logo
search more_vert
person Sign In / Create Account
Looking to 2018 in Myeloma Care with Robert Z. Orlowski, MD, PhD, MD Anderson Cancer Center
Looking to 2018 in Myeloma Care with Robert Z. Orlowski, MD, PhD, MD Anderson Cancer Center image

Jan 05, 2018 / 11:00AM MST
HealthTree Podcast for Multiple Myeloma

Also listen to us on:

spotify apple podcast apple podcast

Episode Summary

Robert Z. Orlowski, MD
MD Anderson Cancer Center
Interview Date: January 5, 2018

Much is happening in the world of myeloma. Where are we headed in 2018? Dr. Robert Z. Orlowski of the MD Anderson Cancer Center joins us to share the latest. He reviews a variety of treatment options for smoldering myeloma, emphasizes the expanded use of daratumumab for all patient settings, reminds us that cyclophosphamide (an older drug) can still be used effectively and reviews the importance of maintenance therapy. He notes the progress of minimal residual disease MRD) testing. He shares the up-and-coming immunotherapies like isatuximab, the new Glaxo-Smith-Klein antibody and the use of venetoclax for patients with the 11;14 translocation. 

Most importantly he shares the importance of being treated by a myeloma specialist. Newly diagnosed patients who see a myeloma specialist can have 40% better overall survival. And in general,  those who are treated by myeloma specialists can live 22% longer than those who don't. To find a myeloma specialist, click here. 

Thanks to our episode sponsor, Takeda Oncology

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us




More Podcast Episodes

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube